Impact of polymorphism in IL-1RA gene on the risk of cervical cancer

Archives of Gynecology and Obstetrics

Volumn 277, Issue 6, 2008, Pages 527-533

  Kordi Tamandani, Dor Mohammad ^a   Sobti, Ranbir Chander ^a   Shekari, Mohammad ^a   Kaur, Satinder ^a   Huria, Anju ^b  

^a PANJAB UNIVERSITY   (India)

^b GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Cervical cancer; HPV; Interleukin 1 receptor antagonist; Polymorphism

Indexed keywords

DNA FRAGMENT; GENOMIC DNA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HETEROZYGOTE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; INTERLEUKIN 1 RECEPTOR ANTAGONIST GENE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS;

ADENOCARCINOMA; ADULT; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; INDIA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 42649145123     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-007-0504-4     Document Type: Article

References (36)

1. Arend WP (1990) Interleukin 1 receptor antagonist: discovery, structure and properties. Prog Growth Factor Res 2:193-205
2. Arend WP, Malyak M, Guthridge CJ, Gabay C (1998) Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 16:27-55
3. Bid HK, Kumar A, Mishra PK, Mittal RD (2004) Study of interleukin-1 receptor antagonist (IL-1RA) gene polymorphism in healthy individuals from Northern India. Indian J Clin Biochem 19(2):119-123
4. Bid HK, Manchanda PK, Mittal RD (2006) Association of interleukin-1RA gene polymorphism in patients with bladder cancer: case control study from North India. Urology 67(5):1099-1104
5. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265
6. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen A M, Peto JM, Schiffman H, Moreno V, Kurman R, Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 87:796
7. Catarino R, Matos A, Pinto D, Pereira D, Craveiro R, Vasconcelos A, Lopes Medeiros R (2005) Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism. Cancer Genet Cytogenet 160(1):49-54
8. Cates W, The American Social Health Association Panel (1999) Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis 26:S2-S7
9. Dinarello CA, Moldawer LL (2003) Proinflammatory and anti-inflammatory cytokines in rheumatoid arthritis. A primer for clinicians. Third edition Amgen, Thousand Oaks
10. Eileen MB (2003) Human papillomavirus and cervical cancer. Clin Microbiol 16:1-17
11. Eisenberg SP, Brewer MT, Verderber E et al (1991) Interleukin-1 receptorantagonist is a member of the interleukin 1 gene family. Evolution of acytokine control mechanism. Proc Natl Acad Sci USA 88:5232-5236
12. El-Omar EM, Carrington M, Chow WH et al (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398-402
13. Eluf-Neto J, Booth M, Munoz N, Bosch F X, Meijer CJ, Walboomers JM (1994) Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 69:114
14. Glas J,Torok HP, Schneider A, Brunnler G, Kopp R, Albert ED, Stolte M, Folwaczny C (2005) Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. J Clin Oncol 23:5272-5273
15. Grimm C, Berger I, Tomovski C, Zeillinger R, Concin N, Leodolter S, Koelbl H, Tempfer CB, Hefler LA (2004) A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis. Gynecol Oncol 92(3):936-940
16. Holowaty P, Miller AB, Rohan T, To T (1999) Natural dysplasia of the uterine cervix. J Natl Cancer Inst 91:252-258
17. Hu Z, Shao M, Chen Y, Zhou J, Qian J, Xu L Ma H, Wang X, Xu Y, Lu D, Shen H (2006) Allele 2 of the interleukin-1 receptor antagonist gene (IL1-RN×2) is associated with a decreased risk of primary lung cancer. Cancer Lett 236(2):269-275
18. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer statistics. CA Cancer J Clin 53:5-26
19. Jeremias J, Ledger WJ, Witkin S (2000) Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am J Obstet Gynecol 182:283-285
20. Machado JC, Pharoah P, Sousa S et al. (2001) Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121:823-829
21. Mantovani A, Dinarello CA, Ghezzi P (Eds) (2000) Interleukin-1 receptor antagonist. In: Pharmacology of cytokines. Oxford University Press, Oxford, pp 91-119
22. Mustea A, Sehouli J, Konsgen D, Stengel D, Sofroni D, Lichtenegger W (2003) Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer. Anticancer Res 23:1099-1102
23. Papadakis ED, Soulitzis N, Spandidos DA (2002) Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes. Br J Cancer 87:1013-1018
24. Roe BA, Crabtree JS, Khan AS (eds) (1995) Methods for DNA isolation. Part III. In: Protocols for recombinant DNA isolation, cloning, and sequencing [Internet edition]. University of Oklahoma, Norman. http://www.genome.ou.edu/ protocol_book/protocol_index.html. Paper copy as: DNA isolation and sequencing. Wiley, New York (1996)
25. Sehouli J, Mustea A, Koensgen D, Chen FC-K, Lichtenegger W (2003) Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer. Ann Oncol 14:1501-1504
26. Sehouli J, Mustea A, Konsgen D, Katsares I, Lichtenegger W (2002) Polymorphism of IL-1 receptor antagonist gene: role in cancer. Anticancer Res 22(6A):3421-3424
27. Shanta V, Krishnamurthi S, Gajalakshmi CK et al (2000) Epidemiology of cancer of the cervix: global and national perspective. J Indian Med Assoc 98:49-52
28. Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ,Walboomers JM (1990) The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 71:173-181
29. Sull JW, Jee SH, Yi S, Lee JE, Park JS, Kim S, Ohrr H (2004) The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women. Gynecol Oncol 95(3):557-563
30. Tarlow JK, Blakemore AF, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86 bp tandem repeat. Hum Genet 91:403-404
31. Unfried G, Tempfer C, Schneeberger C et al (2001) Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 75:683-687
32. Viet HT, Wagsater D, Hugander A, Dimberg J (2005) Interleukin-1 receptor antagonist gene polymorphism in human colorectal cancer. Oncol Rep 14(4):915-918
33. Witkin SS, Gerber S, Ledger WJ (2002) Influence of interleukin-1 receptorantagonist gene polymorphism on disease. Clin Infect Dis 34:204-209
34. Zienolddiny S, Ryberg D, Maggini V, Skaug V, Canzian F, Haugen A (2004) Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer 109(3):353-356
35. zur Hausen H (1996) Papillomavirus infections: a major cause of human cancers. Biochim Biophys Acta 1288:F55
36. zur Hausen H (1999) Papillomaviruses in human cancers. Proc Assoc Am Physicians 111:581-587